Baker Brothers Advisors - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 201 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$5,376,000
-59.8%
429,063
-50.0%
0.02%
-54.0%
Q4 2020$13,379,000
+49.1%
857,339
-9.7%
0.05%
+38.9%
Q3 2020$8,976,000
+0.2%
949,823
-5.0%
0.04%
-10.0%
Q2 2020$8,958,000
+40.7%
999,8230.0%0.04%
+2.6%
Q1 2020$6,369,000
-23.9%
999,8230.0%0.04%
-11.4%
Q4 2019$8,369,000
-7.5%
999,8230.0%0.04%
-29.0%
Q3 2019$9,048,000
-16.0%
999,8230.0%0.06%
-15.1%
Q2 2019$10,768,000
+12.9%
999,8230.0%0.07%
+19.7%
Q1 2019$9,538,000
-16.9%
999,8230.0%0.06%
-35.1%
Q4 2018$11,478,000
-47.3%
999,823
-22.1%
0.09%
-34.3%
Q3 2018$21,762,000
+19.4%
1,283,9230.0%0.14%
+4.4%
Q2 2018$18,232,000
-40.3%
1,283,923
-20.1%
0.14%
-47.1%
Q1 2018$30,544,000
-11.9%
1,607,579
-23.9%
0.26%
-13.7%
Q4 2017$34,659,000
+9.3%
2,113,3760.0%0.30%
+16.7%
Q3 2017$31,701,000
-12.4%
2,113,376
-48.6%
0.26%
-18.7%
Q2 2017$36,198,000
+53.6%
4,113,376
-9.2%
0.32%
+63.7%
Q1 2017$23,561,000
+90.5%
4,530,901
+11.7%
0.19%
+59.5%
Q4 2016$12,370,000
-34.1%
4,055,8760.0%0.12%
-28.8%
Q3 2016$18,779,000
-20.0%
4,055,8760.0%0.17%
-30.9%
Q2 2016$23,484,000
-4.3%
4,055,8760.0%0.25%
-5.0%
Q1 2016$24,538,000
-33.7%
4,055,8760.0%0.26%
-15.6%
Q4 2015$37,030,000
+74.8%
4,055,876
+8.0%
0.31%
+56.6%
Q3 2015$21,183,000
-40.9%
3,755,876
+16.2%
0.20%
-37.6%
Q2 2015$35,831,000
+62.7%
3,230,932
+130.0%
0.31%
+71.6%
Q1 2015$22,023,000
+51.6%
1,404,544
+47.0%
0.18%
+23.6%
Q4 2014$14,531,000
+55.8%
955,332
+10.5%
0.15%
+26.5%
Q3 2014$9,327,000
+16.8%
864,856
+65.4%
0.12%
+19.4%
Q2 2014$7,983,000
-15.5%
522,7640.0%0.10%
-18.3%
Q1 2014$9,452,000
+60.4%
522,764
+23.2%
0.12%
+44.6%
Q4 2013$5,894,000
+217.9%
424,308
+140.1%
0.08%
+219.2%
Q3 2013$1,854,000176,7070.03%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
WASATCH ADVISORS LP 17,986,781$10,788,4710.07%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 254,257$12,7900.03%
GSA CAPITAL PARTNERS LLP 559,731$3360.03%
Rokos Capital Management LLP 6,474,348$3,940,9360.03%
Long Focus Capital Management, LLC 1,372,000$822,9260.03%
Golden State Equity Partners 166,265$99,7260.03%
State of Wyoming 92,360$55,3980.01%
ExodusPoint Capital Management, LP 1,890,425$1,1340.01%
Fort Sheridan Advisors LLC 53,831$32,2880.01%
ACADIAN ASSET MANAGEMENT LLC 2,927,769$1,7530.01%
View complete list of SANGAMO THERAPEUTICS INC shareholders